2Wissel J, Ward AB, Erztgaard P, et al. European consensus table on the use of botulinum toxin type A in adult spasticity. J Rehabi 1 Med ,2009,41 ( 1 ) : 13-25.
4L Kamen H, Henney J, Runyan. A practical overview of tizanidine use for spasticity secondary to multiple sclerosis, stroke and spinal cord injury. Curr Med Res,2008,24(2) :425-439.
5Kuijk AA, Hendricks HT, Pasman JW, et al. Are clinical character istics as sociated with upper extremity hyper- tonia in severe is ch- aemic supr at entorial stroke?. Journal of rehabilitation medicine, 2007,39( 1 ) :33-37.
6Verplancke D, Snape S, Salisbury CF, et al. A randomized con- trolled trial of botulinum toxin on lower limb spasticity following a- cute acquired severe brain injury. Clinical rehabilitation,2005,19 (2) :117- 125.
7Eric Lapeyre,Jan BM, Willem J, et al. Spasticity: Revi- siting the role and the individual value of sever alpharmacological treatments. Neuro Rehabilitation. 2010. 27 ( 2 ) : 193-200.
